As an increasing number of candidates enter the clinic and promise to be a mainstay in the future of cancer treatment, cell therapies pose unique supply chain challenges.

From time and temperature sensitivity, to patient-facing services and integrated platforms, a seamless vein-to-vein supply chain is central in maintaining cell immunotherapy safety and efficacy at scale and maximizing the patient experience.

This October join industry experts from large pharma, biotech, standards agencies and supply chain and logistics service providers. Hear 16+ real-world case studies led by supply chain, strategic sourcing, apheresis, and technical operations experts from top cell therapy providers. Ensure effective forecasting, risk management, quality assurance and service at scale to meet clinical to commercial demand.

Build, adapt and coordinate the vein-to-vein supply of life-changing cell therapies, virtually network and establish yourself in the cell therapy supply chain community, and share your own experiences to help develop best practice in vein-to-vein cell therapy supply.